ArticleBJS open2026

Tolerability of dose-escalating early postoperative intraperitoneal chemotherapy in colorectal cancer with peritoneal disease: EFFIPEC single-arm phase I study.

Elinor Bexe Lindskog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.